FIDIA FARMACEUTICI (Hyalgan)
ABOUT THE BRAND
Fidia Farmaceutici is one of the earliest pharmaceutical groups in Italy, founded back in 1946 in Bologna. By 1959 the headquarters moved to Abano Terme in Padua province, and it has stayed there since then. From being bankrupt in 1994 to achieving over $350 million in revenue in 2019, the company has faced many hurdles throughout its long history, and it also has more than its fair share of victories as well. The company offers a wide variety of products in the aesthetic injectable range which include Hyal System, Hyalgan, and Hymovis.
Hyalgan is a viscosupplement that was developed for advanced treatment in knee osteoarthritis pain, to be used when non-invasive treatment and other pharmaceuticals have failed to provide adequate relief. It contains highly viscous sodium, hyaluronate, and has also been proven to be effective as a therapy replacement, providing relief in lieu of mobility support products or pain killers.
Hymovis is an intra-articular implant that has the ability to also relive osteoarthritic pain, but can also be used to conservatively treat the meniscal lesion. Making use of patented technology, this product is intended to replace lost or degraded synovial fluid, making the knee joint more flexible and not degrade the connected bones.
Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.